Saupe J, Hirschberg R, Höfer W, Bosaller W, von Herrath D, Pauls A, Schaefer K
Nephron. 1986;43(4):290-2. doi: 10.1159/000183856.
Studies in uremic rats were performed to see whether or not the long-term administration of therapeutical doses of 1,25-Dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 would induce histological changes in the aorta or increase the calcium content of the aorta or the heart. In contrast to observations of others, no effect of both vitamin D sterols could be observed on both investigated tissues. However, the remnant kidneys of the rats treated with both vitamin D compounds showed a significantly increased calcium content. According to these results one cannot exclude that the chronic application of active vitamin D metabolites has induced a calcium deposition in the remnant kidney. This finding deserves special attention, although we found, on the other hand, no evidence that an underlying arterial disease is aggravated by this therapy.
对尿毒症大鼠进行了研究,以观察长期给予治疗剂量的1,25 - 二羟基维生素D3或1α - 羟基维生素D3是否会引起主动脉的组织学变化,或增加主动脉或心脏的钙含量。与其他人的观察结果相反,在两个被研究的组织中均未观察到两种维生素D甾醇有任何作用。然而,用两种维生素D化合物处理的大鼠的残余肾脏显示钙含量显著增加。根据这些结果,不能排除活性维生素D代谢物的长期应用已导致残余肾脏中钙沉积。这一发现值得特别关注,尽管另一方面我们没有发现证据表明这种治疗会加重潜在的动脉疾病。